Felix Mayer
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Felix Mayer has a total of 62 co-authors. Here are the top co-authors by number of shared publications:
St. Ritz-Timme
Institute of Legal Medicine, University Hospital Düsseldorf, Düsseldorf, Germany
8 shared publicationsR. Huhn
Departement of Anesthesiology, the University Hospital Düsseldorf, Düsseldorf, Germany
4 shared publicationsM. Jühling
Institute of Legal Medicine, University Hospital Düsseldorf, Düsseldorf, Germany
3 shared publicationsStefanie Ritz-Timme
Institute of Legal Medicine, University Hospital Düsseldorf, Düsseldorf, Germany
3 shared publicationsV. Wolf
Institute of Legal Medicine, University Hospital Düsseldorf, Düsseldorf, Germany
3 shared publicationsAnnika Raupach
Department of Anaesthesiology, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
2 shared publications
Latest Publications
- Open Access
- 12 November 2026
- Published by Springer Nature in International journal of legal medicine
- p. 1-10
MicroRNA-1 and microRNA-499 as potential time-dependent biomarkers for the detection of early myocardial ischaemia
Post-mortem diagnosis of acute myocardial infarction (AMI) remains one of the major challenges in forensic pathology, as conventional macroscopic, histological and immunohistochemical techniques lack sufficient sensitivity within the first hour after onset of ischaemia. Using the established isolated-perfused rat heart model according to Langendorff, this study aimed to evaluate the feasibility and diagnostic potential of myocardial microRNA (miRNA) expression analysis for detecting very early ischaemic conditions. Myocardial expression patterns of four cardiac-enriched miRNAs (miRNA-1-3p, miRNA-133a-3p, miRNA-208a-3p and miRNA-499-5p) were investigated. After 30 min of ischaemia, distinct upregulation of miRNA-1 and miRNA-499 was observed in ischaemic myocardium. Following prolonged ischaemia of 240 min, expression levels of all four miRNAs declined in ischaemic myocardial tissue. These findings suggest an early, transient increase in selected cardiac-enriched miRNAs followed by a decrease with ongoing ischaemia, reflecting a dynamic, time-dependent regulation pattern. Our data demonstrate that myocardial miRNA alterations occur within 30 min of ischaemia. Specifically, we identified miRNA-1 and miRNA-499 as promising early indicators of acute ischemic myocardial injury. Thus, miRNA expression profiling may serve as a valuable adjunct to established forensic diagnostic approaches, particularly when survival times are short and conventional morphological methods reach their limits. Further validation in human post-mortem material is necessary to confirm the diagnostic applicability.
- 12 November 2026
- Published by Springer Nature in International journal of legal medicine
- p. 1-10
Open AccessMicroRNA-1 and microRNA-499 as potential time-dependent biomarkers for the detection of early myocardial ischaemia
Post-mortem diagnosis of acute myocardial infarction (AMI) remains one of the major challenges in forensic pathology, as conventional macroscopic, histological and immunohistochemical techniques lack sufficient sensitivity within the first hour after onset of ischaemia. Using the established isolated-perfused rat heart model according to Langendorff, this study aimed to evaluate the feasibility and diagnostic potential of myocardial microRNA (miRNA) expression analysis for detecting very early ischaemic conditions. Myocardial expression patterns of four cardiac-enriched miRNAs (miRNA-1-3p, miRNA-133a-3p, miRNA-208a-3p and miRNA-499-5p) were investigated. After 30 min of ischaemia, distinct upregulation of miRNA-1 and miRNA-499 was observed in ischaemic myocardium. Following prolonged ischaemia of 240 min, expression levels of all four miRNAs declined in ischaemic myocardial tissue. These findings suggest an early, transient increase in selected cardiac-enriched miRNAs followed by a decrease with ongoing ischaemia, reflecting a dynamic, time-dependent regulation pattern. Our data demonstrate that myocardial miRNA alterations occur within 30 min of ischaemia. Specifically, we identified miRNA-1 and miRNA-499 as promising early indicators of acute ischemic myocardial injury. Thus, miRNA expression profiling may serve as a valuable adjunct to established forensic diagnostic approaches, particularly when survival times are short and conventional morphological methods reach their limits. Further validation in human post-mortem material is necessary to confirm the diagnostic applicability.
- Open Access
- 12 January 2024
- Published by Springer Nature in International journal of legal medicine
- Vol. 138 (3) , 823-831
Cardiac effects of 5F-Cumyl-PEGACLONE
Synthetic cannabinoids become increasingly popular as a supposedly safe and legal alternative to cannabis. In order to circumvent the German New Psychoactive Substances Law, producers of so-called herbal mixtures rapidly design new substances with structural alterations that are not covered by the law. Acting as full agonists not only at the cannabinoid receptors 1 and 2, synthetic cannabinoids might have not only desired mental but also serious physical adverse effects. However, knowledge of adverse effects of specific substances is sparse and incomplete. This also accounts for 5F-Cumyl-PEGACLONE, a synthetic cannabinoid, which has been detected regularly in Germany in recent years. By using an animal model, the isolated perfused Langendorff heart, the study at hand aimed on finding out more about possible cardiovascular adverse effects of 5F-Cumyl-PEGACLONE. Hearts of male Wistar rats, which were excised postmortem, were exposed to two different concentrations of 5F-Cumyl-PEGACLONE: 13 hearts were exposed to 50 ng/ml and 12 hearts were exposed to 100 ng/ml. Thirteen control hearts were merely exposed to an additional amount of buffer solution. Functional parameters heart rate, minimal and maximum left ventricular pressure and coronary flow were documented at pre-defined time points during and after the administration of 5F-Cumyl-PEGACLONE/additional buffer solution. Electrocardiograms (ECGs) were documented throughout the experiments and evaluated afterwards. Kruskal–Wallis analysis was performed for each functional parameter as well as for the duration of the QRS complexes and the duration of RR intervals as derived from the ECGs. Furthermore, a multivariate analysis, comprising all functional and ECG parameters, was performed. Kruskal–Wallis analysis revealed only single significant p-values for QRS duration and minimum left ventricular pressure that did not pass a Bonferroni test. The results of the multivariate approach were also comparably homogeneous, but still the model correctly recognized hearts exposed to 100 ng/ml of 5F-Cumyl-PEGACLONE more often than hearts exposed to the low concentration of 5F-Cumyl-PEGACLONE or additional buffer solution. Evaluation of the ECGs presented single cases of ST depression and QT prolongation. Though certainly not unambiguous, these findings support the assumption that 5F-Cumyl-PEGACLONE can cause severe, if not lethal, cardiac adverse effects like arrhythmias or myocardial infarctions especially if it is consumed in combination with other drugs like alcohol or if the consumer suffers from pre-existing heart diseases.
- 12 January 2024
- Published by Springer Nature in International journal of legal medicine
- Vol. 138 (3) , 823-831
Open AccessCardiac effects of 5F-Cumyl-PEGACLONE
Synthetic cannabinoids become increasingly popular as a supposedly safe and legal alternative to cannabis. In order to circumvent the German New Psychoactive Substances Law, producers of so-called herbal mixtures rapidly design new substances with structural alterations that are not covered by the law. Acting as full agonists not only at the cannabinoid receptors 1 and 2, synthetic cannabinoids might have not only desired mental but also serious physical adverse effects. However, knowledge of adverse effects of specific substances is sparse and incomplete. This also accounts for 5F-Cumyl-PEGACLONE, a synthetic cannabinoid, which has been detected regularly in Germany in recent years. By using an animal model, the isolated perfused Langendorff heart, the study at hand aimed on finding out more about possible cardiovascular adverse effects of 5F-Cumyl-PEGACLONE. Hearts of male Wistar rats, which were excised postmortem, were exposed to two different concentrations of 5F-Cumyl-PEGACLONE: 13 hearts were exposed to 50 ng/ml and 12 hearts were exposed to 100 ng/ml. Thirteen control hearts were merely exposed to an additional amount of buffer solution. Functional parameters heart rate, minimal and maximum left ventricular pressure and coronary flow were documented at pre-defined time points during and after the administration of 5F-Cumyl-PEGACLONE/additional buffer solution. Electrocardiograms (ECGs) were documented throughout the experiments and evaluated afterwards. Kruskal–Wallis analysis was performed for each functional parameter as well as for the duration of the QRS complexes and the duration of RR intervals as derived from the ECGs. Furthermore, a multivariate analysis, comprising all functional and ECG parameters, was performed. Kruskal–Wallis analysis revealed only single significant p-values for QRS duration and minimum left ventricular pressure that did not pass a Bonferroni test. The results of the multivariate approach were also comparably homogeneous, but still the model correctly recognized hearts exposed to 100 ng/ml of 5F-Cumyl-PEGACLONE more often than hearts exposed to the low concentration of 5F-Cumyl-PEGACLONE or additional buffer solution. Evaluation of the ECGs presented single cases of ST depression and QT prolongation. Though certainly not unambiguous, these findings support the assumption that 5F-Cumyl-PEGACLONE can cause severe, if not lethal, cardiac adverse effects like arrhythmias or myocardial infarctions especially if it is consumed in combination with other drugs like alcohol or if the consumer suffers from pre-existing heart diseases.
- Open Access
- 21 July 2023
- Published by Springer Nature in International journal of legal medicine
- Vol. 137 (6) , 1941
Impact of (forensic) expert opinions according to the Istanbul Protocol in Germany—results and insights of the in:Fo-project—reply to commentary of C. Cattaneo and L. Franceschetti
- 21 July 2023
- Published by Springer Nature in International journal of legal medicine
- Vol. 137 (6) , 1941
Open AccessImpact of (forensic) expert opinions according to the Istanbul Protocol in Germany—results and insights of the in:Fo-project—reply to commentary of C. Cattaneo and L. Franceschetti
- Open Access
- 14 February 2023
- Published by Springer Nature in International journal of legal medicine
- Vol. 137 (3) , 863-873
Impact of (forensic) expert opinions according to the Istanbul Protocol in Germany—results and insights of the in:Fo-project
As part of a third-party funded project, expert opinions according to the Istanbul Protocol (IP) standards were compiled in Germany on a larger scale for the first time. The assessment process was initiated for 130 project participants. Statistical analysis on numerous variables was performed to test the impact of the expert opinions, foremost of the forensic medical expert opinions, on the individuals’ asylum proceedings. The variables were drawn from forensic medical expert opinions and reports of findings, questionnaires for the study participants’ counsellors in the project and a query on the asylum status of the study participants. Regression analysis and bivariate analysis on two dependent variables—subjective impact on the asylum procedure from the counsellors’ point of view and objective change in the asylum status—were performed to test for an influence on asylum procedures. No statistically significant results were obtained for the objective change of the study participants’ asylum status. For the subjective dependent variable, a positive prediction was possible when simultaneously controlling for the independent variables introduction of a forensic medical expert opinion and highest IP grade; a negative prediction was possible when simultaneously controlling for the independent variables introduction of a forensic medical expert opinion and use of IP grading. Apart from the statistical analysis, a positive effect of the assessment on the psychosocial well-being of the study participants could be demonstrated. The results differed from other European studies which demonstrated a correlation between the objective outcome of an asylum procedure (asylum status) and, for example, specific types of violence or the number of documented injuries. Differences also occurred in the use of the plausibility grades proposed by the IP, which questions their use in cases in which the reported torture happened a relevant time ago. Therefore, compiling individually worded evaluations instead of using the IP grading system—if possible, by an experienced forensic physician—is recommended in this scenario. Still, the assessment of alleged torture experiences should follow the IP guidelines, since psychological assessments are of especially high importance in cases with healed physical injuries and since the results also demonstrated a positive effect on the psychosocial well-being of the study participants.
- 14 February 2023
- Published by Springer Nature in International journal of legal medicine
- Vol. 137 (3) , 863-873
Open AccessImpact of (forensic) expert opinions according to the Istanbul Protocol in Germany—results and insights of the in:Fo-project
As part of a third-party funded project, expert opinions according to the Istanbul Protocol (IP) standards were compiled in Germany on a larger scale for the first time. The assessment process was initiated for 130 project participants. Statistical analysis on numerous variables was performed to test the impact of the expert opinions, foremost of the forensic medical expert opinions, on the individuals’ asylum proceedings. The variables were drawn from forensic medical expert opinions and reports of findings, questionnaires for the study participants’ counsellors in the project and a query on the asylum status of the study participants. Regression analysis and bivariate analysis on two dependent variables—subjective impact on the asylum procedure from the counsellors’ point of view and objective change in the asylum status—were performed to test for an influence on asylum procedures. No statistically significant results were obtained for the objective change of the study participants’ asylum status. For the subjective dependent variable, a positive prediction was possible when simultaneously controlling for the independent variables introduction of a forensic medical expert opinion and highest IP grade; a negative prediction was possible when simultaneously controlling for the independent variables introduction of a forensic medical expert opinion and use of IP grading. Apart from the statistical analysis, a positive effect of the assessment on the psychosocial well-being of the study participants could be demonstrated. The results differed from other European studies which demonstrated a correlation between the objective outcome of an asylum procedure (asylum status) and, for example, specific types of violence or the number of documented injuries. Differences also occurred in the use of the plausibility grades proposed by the IP, which questions their use in cases in which the reported torture happened a relevant time ago. Therefore, compiling individually worded evaluations instead of using the IP grading system—if possible, by an experienced forensic physician—is recommended in this scenario. Still, the assessment of alleged torture experiences should follow the IP guidelines, since psychological assessments are of especially high importance in cases with healed physical injuries and since the results also demonstrated a positive effect on the psychosocial well-being of the study participants.
- Open Access
- 8 December 2022
- Published by Springer Nature in Rechtsmedizin
- Vol. 33 (2) , 81-87
Forensisch-medizinische Untersuchung von Menschen mit Foltererleben
- 8 December 2022
- Published by Springer Nature in Rechtsmedizin
- Vol. 33 (2) , 81-87
Open AccessForensisch-medizinische Untersuchung von Menschen mit Foltererleben
- Open Access
- 12 May 2022
- Published by Springer Nature in International journal of legal medicine
- Vol. 136 (4) , 987-996
Altered DNA methylation at age-associated CpG sites in children with growth disorders: impact on age estimation?
Age estimation based on DNA methylation (DNAm) can be applied to children, adolescents and adults, but many CG dinucleotides (CpGs) exhibit different kinetics of age-associated DNAm across these age ranges. Furthermore, it is still unclear how growth disorders impact epigenetic age predictions, and this may be particularly relevant for a forensic application. In this study, we analyzed buccal mucosa samples from 95 healthy children and 104 children with different growth disorders. DNAm was analysed by pyrosequencing for 22 CpGs in the genes PDE4C, ELOVL2, RPA2, EDARADD and DDO. The relationship between DNAm and age in healthy children was tested by Spearman’s rank correlation. Differences in DNAm between the groups “healthy children” and the (sub-)groups of children with growth disorders were tested by ANCOVA. Models for age estimation were trained (1) based on the data from 11 CpGs with a close correlation between DNAm and age (R ≥ 0.75) and (2) on five CpGs that also did not present significant differences in DNAm between healthy and diseased children. Statistical analysis revealed significant differences between the healthy group and the group with growth disorders (11 CpGs), the subgroup with a short stature (12 CpGs) and the non-short stature subgroup (three CpGs). The results are in line with the assumption of an epigenetic regulation of height-influencing genes. Age predictors trained on 11 CpGs with high correlations between DNAm and age revealed higher mean absolute errors (MAEs) in the group of growth disorders (mean MAE 2.21 years versus MAE 1.79 in the healthy group) as well as in the short stature (sub-)groups; furthermore, there was a clear tendency for overestimation of ages in all growth disorder groups (mean age deviations: total growth disorder group 1.85 years, short stature group 1.99 years). Age estimates on samples from children with growth disorders were more precise when using a model containing only the five CpGs that did not present significant differences in DNAm between healthy and diseased children (mean age deviations: total growth disorder group 1.45 years, short stature group 1.66 years). The results suggest that CpGs in genes involved in processes relevant for growth and development should be avoided in age prediction models for children since they may be sensitive for alterations in the DNAm pattern in cases of growth disorders.
- 12 May 2022
- Published by Springer Nature in International journal of legal medicine
- Vol. 136 (4) , 987-996
Open AccessAltered DNA methylation at age-associated CpG sites in children with growth disorders: impact on age estimation?
Age estimation based on DNA methylation (DNAm) can be applied to children, adolescents and adults, but many CG dinucleotides (CpGs) exhibit different kinetics of age-associated DNAm across these age ranges. Furthermore, it is still unclear how growth disorders impact epigenetic age predictions, and this may be particularly relevant for a forensic application. In this study, we analyzed buccal mucosa samples from 95 healthy children and 104 children with different growth disorders. DNAm was analysed by pyrosequencing for 22 CpGs in the genes PDE4C, ELOVL2, RPA2, EDARADD and DDO. The relationship between DNAm and age in healthy children was tested by Spearman’s rank correlation. Differences in DNAm between the groups “healthy children” and the (sub-)groups of children with growth disorders were tested by ANCOVA. Models for age estimation were trained (1) based on the data from 11 CpGs with a close correlation between DNAm and age (R ≥ 0.75) and (2) on five CpGs that also did not present significant differences in DNAm between healthy and diseased children. Statistical analysis revealed significant differences between the healthy group and the group with growth disorders (11 CpGs), the subgroup with a short stature (12 CpGs) and the non-short stature subgroup (three CpGs). The results are in line with the assumption of an epigenetic regulation of height-influencing genes. Age predictors trained on 11 CpGs with high correlations between DNAm and age revealed higher mean absolute errors (MAEs) in the group of growth disorders (mean MAE 2.21 years versus MAE 1.79 in the healthy group) as well as in the short stature (sub-)groups; furthermore, there was a clear tendency for overestimation of ages in all growth disorder groups (mean age deviations: total growth disorder group 1.85 years, short stature group 1.99 years). Age estimates on samples from children with growth disorders were more precise when using a model containing only the five CpGs that did not present significant differences in DNAm between healthy and diseased children (mean age deviations: total growth disorder group 1.45 years, short stature group 1.66 years). The results suggest that CpGs in genes involved in processes relevant for growth and development should be avoided in age prediction models for children since they may be sensitive for alterations in the DNAm pattern in cases of growth disorders.
- 9 July 2021
- Published by Springer Nature in Rechtsmedizin
- Vol. 31 (5) , 463-473
Grundlagen der Begutachtung von kinderpornografischen Abbildungen in der Rechtsmedizin
- 9 July 2021
- Published by Springer Nature in Rechtsmedizin
- Vol. 31 (5) , 463-473
Grundlagen der Begutachtung von kinderpornografischen Abbildungen in der Rechtsmedizin
- Open Access
- 26 May 2021
- Published by Springer Nature in International journal of legal medicine
- Vol. 135 (5) , 1843-1853
Complex challenges of estimating the age and vitality of muscle wounds: a study with matrix metalloproteinases and their inhibitors on animal and human tissue samples
The estimation of wound age and wound vitality is a recurring task in forensic routine work and has been subject of forensic research for a long time. By now, an unrestrictedly reliable marker or set of markers has not been found. In a study on myocardial infarctions, matrix metalloproteinases (MMP) 2 and 9 as well as tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) were detected immunohistochemically in mechanically wounded myocardium (ECG electrodes, vessel ligations). Against this background, the potency of MMP-9, MMP-2, and TIMP-1 as markers for the estimation of wound age and wound vitality was tested in a broad approach with human tissue samples drawn during autopsies and with an animal model, the isolated perfused Langendorff heart. The study comprised samples of injured human skeletal muscle, injured human myocardium, rats’ hearts with vital wounds, and rats’ hearts with postmortem-inflicted wounds that were all stained immunohistochemically. The results showed great scattering, leading to the conclusion that MMP-2, MMP-9, and TIMP-1 are not suitable for wound age estimation. Merely the results for TIMP-1 suggested that this marker might be able to differentiate between vital and postmortem-inflicted wounds. With a view to the promising results of the preceding study, the results underline the necessity to test possible markers of wound age/wound vitality on a large and diverse sample set.
- 26 May 2021
- Published by Springer Nature in International journal of legal medicine
- Vol. 135 (5) , 1843-1853
Open AccessComplex challenges of estimating the age and vitality of muscle wounds: a study with matrix metalloproteinases and their inhibitors on animal and human tissue samples
The estimation of wound age and wound vitality is a recurring task in forensic routine work and has been subject of forensic research for a long time. By now, an unrestrictedly reliable marker or set of markers has not been found. In a study on myocardial infarctions, matrix metalloproteinases (MMP) 2 and 9 as well as tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) were detected immunohistochemically in mechanically wounded myocardium (ECG electrodes, vessel ligations). Against this background, the potency of MMP-9, MMP-2, and TIMP-1 as markers for the estimation of wound age and wound vitality was tested in a broad approach with human tissue samples drawn during autopsies and with an animal model, the isolated perfused Langendorff heart. The study comprised samples of injured human skeletal muscle, injured human myocardium, rats’ hearts with vital wounds, and rats’ hearts with postmortem-inflicted wounds that were all stained immunohistochemically. The results showed great scattering, leading to the conclusion that MMP-2, MMP-9, and TIMP-1 are not suitable for wound age estimation. Merely the results for TIMP-1 suggested that this marker might be able to differentiate between vital and postmortem-inflicted wounds. With a view to the promising results of the preceding study, the results underline the necessity to test possible markers of wound age/wound vitality on a large and diverse sample set.
- Open Access
- 6 May 2020
- Published by Springer Nature in International journal of legal medicine
- Vol. 134 (5) , 1741-1752
Effects of cocaine and levamisole (as adulterant) on the isolated perfused Langendorff heart
Cocaine-related deaths occur regularly in forensic routine work. In cases in which the detected concentration of cocaine is rather low and other causes of death apart from intoxication can be ruled out, the question arises if adulterants of cocaine might have played a crucial role. In the present study, cardiac effects of cocaine, of the adulterant levamisole and of mixtures of both were evaluated using the isolated perfused Langendorff heart. While exposed to the substances, functional parameters heart rate, left ventricular pressure and coronary flow were documented. Relevant alterations of these parameters were found for cocaine as well as for levamisole. Exposing the hearts to a mixture of both resulted in a combination of these effects; the emergence of new alterations or an obvious aggravation were not detected. Nevertheless, the results imply that the consumption of cocaine adulterated with levamisole bares an increased risk for cardiac complications, especially in the presence of preexisting cardiac pathologies.
- 6 May 2020
- Published by Springer Nature in International journal of legal medicine
- Vol. 134 (5) , 1741-1752
Open AccessEffects of cocaine and levamisole (as adulterant) on the isolated perfused Langendorff heart
Cocaine-related deaths occur regularly in forensic routine work. In cases in which the detected concentration of cocaine is rather low and other causes of death apart from intoxication can be ruled out, the question arises if adulterants of cocaine might have played a crucial role. In the present study, cardiac effects of cocaine, of the adulterant levamisole and of mixtures of both were evaluated using the isolated perfused Langendorff heart. While exposed to the substances, functional parameters heart rate, left ventricular pressure and coronary flow were documented. Relevant alterations of these parameters were found for cocaine as well as for levamisole. Exposing the hearts to a mixture of both resulted in a combination of these effects; the emergence of new alterations or an obvious aggravation were not detected. Nevertheless, the results imply that the consumption of cocaine adulterated with levamisole bares an increased risk for cardiac complications, especially in the presence of preexisting cardiac pathologies.
- Open Access
- 18 March 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (3) , 375
Cardioprotective Properties of Omecamtiv Mecarbil against Ischemia and Reperfusion Injury
Omecamtiv mecarbil (OM) is a first-in-class myosin activator. It was developed as a new inotropic therapy option for heart failure and is currently the object of a phase 3 clinical trial program. OM activates ryanodine receptors, which were shown to be involved in cardioprotection induced by conditioning strategies. We hypothesize that OM exerts a concentration-dependent cardioprotective effect through pre- and postconditioning. Isolated male Wistar rat hearts underwent 33 min of global ischemia and 60 min of reperfusion. OM was administered in various concentrations (1, 3, 10, and 30 µM) over 10 min prior to ischemia. Based on these results, in subsequent experiments 3 and 10 µM OM were given over 10 min after ischemia. Infarct sizes were determined by TTC staining. In controls, the infarct size was 60% ± 10% and 59% ± 12%, respectively. Ten micromolar OM before ischemia reduced the infarct size to 33% ± 8%. The lower concentrations did not initiate cardioprotection, and the next highest concentration did not enhance the protective effect. Even if 10 μM OM was given in the early reperfusion phase, it significantly reduced the infarct size (31% ± 6%), whereas 3 μM OM did not trigger a protective effect (58% ± 15%). This study shows for the first time that OM induces cardioprotection by pre- and postconditioning with a binary phenomenon, which is either ineffective or has a maximal effect.
- 18 March 2019
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (3) , 375
Open AccessCardioprotective Properties of Omecamtiv Mecarbil against Ischemia and Reperfusion Injury
Omecamtiv mecarbil (OM) is a first-in-class myosin activator. It was developed as a new inotropic therapy option for heart failure and is currently the object of a phase 3 clinical trial program. OM activates ryanodine receptors, which were shown to be involved in cardioprotection induced by conditioning strategies. We hypothesize that OM exerts a concentration-dependent cardioprotective effect through pre- and postconditioning. Isolated male Wistar rat hearts underwent 33 min of global ischemia and 60 min of reperfusion. OM was administered in various concentrations (1, 3, 10, and 30 µM) over 10 min prior to ischemia. Based on these results, in subsequent experiments 3 and 10 µM OM were given over 10 min after ischemia. Infarct sizes were determined by TTC staining. In controls, the infarct size was 60% ± 10% and 59% ± 12%, respectively. Ten micromolar OM before ischemia reduced the infarct size to 33% ± 8%. The lower concentrations did not initiate cardioprotection, and the next highest concentration did not enhance the protective effect. Even if 10 μM OM was given in the early reperfusion phase, it significantly reduced the infarct size (31% ± 6%), whereas 3 μM OM did not trigger a protective effect (58% ± 15%). This study shows for the first time that OM induces cardioprotection by pre- and postconditioning with a binary phenomenon, which is either ineffective or has a maximal effect.